ONCE - Spark Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue64,72512,06620,18322,063.674
Cost of Revenue7,915---
Gross Profit56,81012,06620,18322,063.674
Operating Expenses
Research Development125,254135,16086,38046,029.314
Selling General and Administrative124,595111,12448,07023,352.171
Non Recurring----
Others----
Total Operating Expenses257,764246,284134,45069,381.485
Operating Income or Loss-193,039-234,218-114,267-47,317.811
Income from Continuing Operations
Total Other Income/Expenses Net114,316-20,227-9,386192.033
Earnings Before Interest and Taxes-193,039-234,218-114,267-47,317.811
Interest Expense----
Income Before Tax-78,723-254,445-123,653-47,125.778
Income Tax Expense99-963--
Minority Interest----
Net Income From Continuing Ops-78,822-253,482-123,653-47,125.778
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-78,822-253,482-123,653-47,125.778
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-78,822-253,482-123,653-47,760.572